Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Miao, Yuan ^a   Wang, Liang ^a   Zhang, Xiupeng ^a   Xu, Xiaohan ^a   Jiang, Guiyang ^a   Fan, Chuifeng ^a   Liu, Yang ^a   Lin, Xuyong ^a   Yu, Juanhan ^a   Zhang, Yong ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BISULFITE; LUCIFERASE; UVOMORULIN; WNT3A PROTEIN; AZACITIDINE; CADHERIN; DECITABINE;

A549 CELL LINE; ADULT; ARTICLE; CANCER CELL LINE; CANCER PROGNOSIS; CANCER STAGING; CASE STUDY; EPIGENETICS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; POLYMERASE CHAIN REACTION; PREDICTION; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR INVASION; AGED; ANALOGS AND DERIVATIVES; CELL MEMBRANE; DNA METHYLATION; DRUG EFFECTS; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

AGED; AZACITIDINE; BETA CATENIN; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MEMBRANE; DNA METHYLATION; FEMALE; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROMOTER REGIONS, GENETIC; WNT SIGNALING PATHWAY;

EID: 84911499062     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112258     Document Type: Article

References (32)

1. Travis WD (2011) Pathology of lung cancer. Clin Chest Med 32: 669-692.
2. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
3. Mareel M, Berx G, Van Roy F, Bracke M (1996) Cadherin/catenin complex: a target for antiinvasive therapy? J Cell Biochem 61: 524-530.
4. Fu Y, Zheng S, An N, Athanasopoulos T, Popplewell L, et al. (2011) beta-catenin as a potential key target for tumor suppression. Int J Cancer 129: 1541-1551.
5. Salon C, Lantuejoul S, Eymin B, Gazzeri S, Brambilla C, et al. (2005) The E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis. Future Oncol 1: 649-660.
6. Konigshoff M, Eickelberg O (2010) WNT signaling in lung disease: a failure or a regeneration signal? Am J Respir Cell Mol Biol 42: 21-31.
7. Van Scoyk M, Randall J, Sergew A, Williams LM, Tennis M, et al. (2008) Wnt signaling pathway and lung disease. Transl Res 151: 175-180.
8. Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, et al. (1999) Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59: 3346-3351.
9. Kase S, Sugio K, Yamazaki K, Okamoto T, Yano T, et al. (2000) Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 6: 4789-4796.
10. Pirinen RT, Hirvikoski P, Johansson RT, Hollmen S, Kosma VM (2001) Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 54: 391-395.
11. Retera JM, Leers MP, Sulzer MA, Theunissen PH (1998) The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study. J Clin Pathol 51: 891-894.
12. Kumper S, Ridley AJ (2010) p120ctn and P-cadherin but not E-cadherin regulate cell motility and invasion of DU145 prostate cancer cells. PLoS One 5: e11801.
13. Belinsky SA (2004) Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4: 707-717.
14. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA (2002) DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 21: 5450-5461.
15. Ebert MP, Yu J, Hoffmann J, Rocco A, Rocken C, et al. (2003) Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol 21: 1708-1714.
16. Liu Y, Dong QZ, Wang S, Xu HT, Miao Y, et al. (2014) Kaiso Interacts with p120-Catenin to Regulate beta-Catenin Expression at the Transcriptional Level. PLoS One 9: e87537.
17. Miao Y, Li AL, Wang L, Fan CF, Zhang XP, et al. (2013) Overexpression of NEDD9 is associated with altered expression of E-Cadherin, beta-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer. Pathol Oncol Res 19: 281-286.
18. Travis WD BE, Müller-Hermelink HK, Haris CC (2004) Pathology and genetics: Tumours of the lung, pleura, thymus and heart. Lyon: IARC Press. 344 p.
19. Goldstraw P (2011) Updated staging system for lung cancer. Surg Oncol Clin N Am 20: 655-666.
20. Kwon MJ, Kwon JH, Nam ES, Shin HS, Lee DJ, et al. (2013) TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma. Hum Pathol 44: 1722-1729.
21. Cho YH, Shen J, Gammon MD, Zhang YJ, Wang Q, et al. (2012) Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat 131: 197-205.
22. Miao Y, Li AL, Wang L, Fan CF, Zhang XP, et al. (2012) Expression of p130cas, E-cadherin and beta-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis. Folia Histochem Cytobiol 50: 392-397.
23. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, et al. (2001) Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249-255.
24. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, et al. (2003) Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 94: 589-592.
25. Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, et al. (2006) The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Cancer 106: 2190-2199.
26. Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, et al. (2005) Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 11: 2466-2470.
27. Vaissiere T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, et al. (2009) Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 69: 243-252.
28. Capaldo CT, Macara IG (2007) Depletion of E-cadherin disrupts establishment but not maintenance of cell junctions in Madin-Darby canine kidney epithelial cells. Mol Biol Cell 18: 189-200.
29. Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, et al. (2003) Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 106: 208-215.
30. Wong AS, Gumbiner BM (2003) Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 161: 1191-1203.
31. Hugh TJ, Dillon SA, O'Dowd G, Getty B, Pignatelli M, et al. (1999) beta-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 82: 504-511.
32. Takahashi Y, Nishikawa M, Suehara T, Takiguchi N, Takakura Y (2008) Gene silencing of beta-catenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in mice. Int J Cancer 123: 2315-2320.